Article info
PDFExtended reports
Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis
- Correspondence to:
Dr H Schotte
Department of Medicine B, Münster University Hospital, Albert-Schweitzer-Str 33, D-48129 Münster, Germany; h.schotteuni-muenster.de
Citation
Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis
Publication history
- Accepted August 22, 2004
- First published September 2, 2004.
Online issue publication
January 09, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Annals of the Rheumatic Diseases